BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Plinabulin readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Plinabulin\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05130827-2260@assetmemo.bio
DTSTAMP:20261121T004525Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:Plinabulin: Phase 2 readout est. (NCT05130827)
DESCRIPTION:Plinabulin\, phase 2.\nStudy: Study of Plinabulin and Pegfilgra
 stim in People With Multiple Myeloma Undergoing an Autologous Hematopoieti
 c Stem Cell Transplant (AHCT)\nEstimated primary completion: November 2026
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/plinabulin#upcoming
 -events\nRegistry record: https://clinicaltrials.gov/study/NCT05130827
URL:https://assetmemo.bio/drug/plinabulin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07361484-2260@assetmemo.bio
DTSTAMP:20261121T004525Z
DTSTART;VALUE=DATE:20290601
DTEND;VALUE=DATE:20290602
SUMMARY:Plinabulin: Phase 3 readout est. (NCT07361484)
DESCRIPTION:Plinabulin\, phase 3\, Non-Small Cell Lung Cancer.\nStudy: Doce
 taxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non
 -Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN
 -4)\nEstimated primary completion: 1 June 2029. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/plinabulin#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT07361484
URL:https://assetmemo.bio/drug/plinabulin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
